Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
DexCom
DXCM
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 13.95%732.8M | -40.83%80.3M | 53.31%440.3M | -16.00%182.2M | 809.09%30M | -14.06%643.1M | -54.71%135.7M | 7.16%287.2M | 23.94%216.9M | -42.11%3.3M |
Net income from continuing operations | 9.59%306.3M | -34.82%45.3M | 45.49%151.6M | -3.26%83.2M | 32.32%26.2M | 21.15%279.5M | 2.51%69.5M | 6.76%104.2M | 50.61%86M | 141.46%19.8M |
Operating gains losses | 338.75%19.1M | 406.03%35.5M | -411.36%-27.4M | 76.19%-1.5M | 1,036.36%12.5M | -128.37%-8M | -48.72%-11.6M | -44.30%8.8M | -142.86%-6.3M | -80.00%1.1M |
Depreciation and amortization | -0.83%131.8M | -2.99%32.5M | 0.30%32.9M | 0.00%33.7M | -0.61%32.7M | -2.21%132.9M | -1.76%33.5M | 0.00%32.8M | -6.39%33.7M | -0.30%32.9M |
Deferred tax | 35.04%18.5M | -77.04%4.5M | 297.22%7.1M | 160.47%2.6M | 115.00%4.3M | 73.42%13.7M | 555.81%19.6M | -140.91%-3.6M | -115.00%-4.3M | -62.96%2M |
Other non cash items | 2.50%4.1M | -10.00%900K | 20.00%1.2M | 0.00%1M | 0.00%1M | 8.11%4M | -23.08%1M | --1M | -16.67%1M | -16.67%1M |
Change In working capital | 24.99%209.1M | -615.79%-49M | 101.29%264.3M | -43.80%53M | 12.68%-59.2M | -43.82%167.3M | -95.12%9.5M | 27.97%131.3M | 62.87%94.3M | -18.12%-67.8M |
-Change in receivables | 241.33%269.8M | 54.63%-157.9M | 276.50%371M | -75.45%-19.3M | -79.91%76M | 36.24%-190.9M | -13.91%-348M | -303.45%-210.2M | 82.26%-11M | 214.73%378.3M |
-Change in prepaid assets | -16.51%35.4M | 44.27%-17.5M | -205.83%-59.9M | -77.41%11.7M | 392.20%101.1M | 122.01%42.4M | -345.31%-31.4M | 208.64%56.6M | 140.53%51.8M | -35.69%-34.6M |
-Change in payables and accrued expense | -116.52%-50.2M | -66.45%122.1M | -98.45%4.4M | 11.95%63.7M | 39.93%-240.4M | -61.87%303.9M | -26.35%363.9M | 60.60%283.3M | -77.57%56.9M | -214.87%-400.2M |
-Change in other working capital | -485.71%-45.9M | -82.80%4.3M | -3,300.00%-51.2M | 8.82%-3.1M | 136.28%4.1M | 263.01%11.9M | 473.13%25M | -94.74%1.6M | 43.33%-3.4M | 54.80%-11.3M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 13.95%732.8M | -40.83%80.3M | 53.31%440.3M | -16.00%182.2M | 809.09%30M | -14.06%643.1M | -54.71%135.7M | 7.16%287.2M | 23.94%216.9M | -42.11%3.3M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -41.69%-223.3M | 54.10%-38.1M | -3.09%-30M | -113.14%-58.4M | -434.81%-96.8M | 65.27%-157.6M | -120.16%-83M | 0.00%-29.1M | 8.97%-27.4M | 94.93%-18.1M |
Net PPE purchase and sale | -24.15%-117.2M | -35.18%-34.2M | 5.15%-25.8M | -43.35%-33.4M | -27.96%-23.8M | 9.49%-94.4M | -1.61%-25.3M | -3.42%-27.2M | 20.48%-23.3M | 21.85%-18.6M |
Net business purchase and sale | -6,946.15%-91.6M | 80.00%-300K | ---500K | ---21.4M | -34,800.00%-69.4M | 99.62%-1.3M | 87.07%-1.5M | --0 | --0 | 100.06%200K |
Net other investing changes | 76.58%-14.5M | 93.59%-3.6M | -94.74%-3.7M | 12.20%-3.6M | -1,300.00%-3.6M | -852.31%-61.9M | -4,583.33%-56.2M | -35.71%-1.9M | -127.78%-4.1M | 114.29%300K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -41.69%-223.3M | 54.10%-38.1M | -3.09%-30M | -113.14%-58.4M | -434.81%-96.8M | 65.27%-157.6M | -120.16%-83M | 0.00%-29.1M | 8.97%-27.4M | 94.93%-18.1M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 5.24%-135.7M | -593.24%-321.1M | 61.94%-119M | 105.06%223.1M | 1,947.73%81.3M | -11,833.33%-143.2M | 137.26%65.1M | 1.57%-312.7M | -57.48%108.8M | -101.87%-4.4M |
Net issuance payments of debt | -47.56%120.3M | -345.67%-278.1M | -26.67%-19M | 211.42%335.4M | 248.94%82M | 32.91%229.4M | 164.72%113.2M | 95.24%-15M | -69.92%107.7M | -92.29%23.5M |
Net common stock issuance | 32.16%-251.4M | 20.70%-38.3M | 66.11%-100.1M | -8,738.46%-112.3M | 97.52%-700K | -122.05%-370.6M | -1,307.50%-48.3M | -42,300.00%-295.4M | 101.26%1.3M | 58.65%-28.2M |
Net other financing activities | -130.00%-4.6M | -2,450.00%-4.7M | ---- | ---- | ---- | 71.01%-2M | 105.26%200K | ---2.3M | ---200K | 123.08%300K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 5.24%-135.7M | -593.24%-321.1M | 61.94%-119M | 105.06%223.1M | 1,947.73%81.3M | -11,833.33%-143.2M | 137.26%65.1M | 1.57%-312.7M | -57.48%108.8M | -101.87%-4.4M |
Net cash flow | ||||||||||
Beginning cash position | 12.87%2.25B | 43.97%2.94B | 16.54%2.56B | 14.27%2.21B | 12.86%2.25B | -4.57%1.99B | 8.77%2.04B | 0.77%2.19B | 0.26%1.94B | -4.56%1.99B |
Current changes in cash | 9.20%373.8M | -336.76%-278.9M | 633.52%291.3M | 16.29%346.9M | 175.52%14.5M | 16.71%342.3M | 35.09%117.8M | 30.71%-54.6M | -25.57%298.3M | 83.43%-19.2M |
Effect of exchange rate changes | -54.01%-132.6M | -303.38%-174.7M | 200.74%95.3M | 86.21%-6M | -39.23%-47.2M | 77.84%-86.1M | 242.23%85.9M | 56.70%-94.6M | 72.42%-43.5M | 9.60%-33.9M |
End cash Position | 10.73%2.49B | 10.73%2.49B | 43.97%2.94B | 16.54%2.56B | 14.27%2.21B | 12.87%2.25B | 12.87%2.25B | 8.77%2.04B | 0.77%2.19B | 0.26%1.94B |
Free cash flow | 12.19%615.6M | -58.24%46.1M | 59.42%414.5M | -23.14%148.8M | 140.52%6.2M | -14.80%548.7M | -59.81%110.4M | 7.57%260M | 32.88%193.6M | 15.47%-15.3M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |